KRN7000 applied to arthritis research

Activation of Invariant NKT Cells with Glycolipid Ligand α-Galactosylceramide Ameliorates Glucose-6-Phosphate Isomerase Peptide-Induced Arthritis

Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis

 

 

 

 

 

 

 

 

 

 

New 7DW8-5 glycolipid

7DW8-5

Now available 7DW8-5 glycolipid derivative of Alpha-GalCer for human and mice iNKT immunoresearch

 

Meet Funakoshi Company
at the following meetings:



ASCB
Philadelphia, PA
December 2-6, 2017